Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Berges

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Der Urologe. Ausg. A|January 31, 2008
[Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50]R Berges
Aktuelle Urologie|September 28, 2006
[Drug therapy for benign prostatic syndrome (BPS)]R Berges
Der Urologe. Ausg. A|March 20, 2009
[Treatment of LUTS in BPS. When and when not to administer pills?]R Berges
Der Urologe. Ausg. A|July 24, 2010
[Certified prostate centers of the DVPZ : Current status]J Zumbe, R Berges
Current Medical Research and Opinion|May 11, 2006
Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancerR Berges, U Bello
Der Urologe. Ausg. A|April 21, 2005
[Drug therapy for benign prostatic hyperplasia. Systematic overview]R Berges, K Höfner
Der Urologe. Ausg. A|August 17, 2014
[Certification system in urological healthcare : a professional political evaluation]R Berges, A Schroeder
Clinical Chemistry|February 1, 1993
Programming events in the regulation of cell proliferation and deathR Berges, J T Isaacs
European Urology|November 24, 1999
Management of the BPH syndrome in Germany: who is treated and how?R R Berges, L Pientka
European Urology|June 1, 2000
Effect of beta-sitosterol on transforming growth factor-beta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitroA Kassen, R Berges, T Senge
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Der Urologe. Ausg. A|January 31, 2008
[Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50]R Berges
Aktuelle Urologie|September 28, 2006
[Drug therapy for benign prostatic syndrome (BPS)]R Berges
Der Urologe. Ausg. A|March 20, 2009
[Treatment of LUTS in BPS. When and when not to administer pills?]R Berges
Der Urologe. Ausg. A|July 24, 2010
[Certified prostate centers of the DVPZ : Current status]J Zumbe, R Berges
Current Medical Research and Opinion|May 11, 2006
Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancerR Berges, U Bello
Der Urologe. Ausg. A|April 21, 2005
[Drug therapy for benign prostatic hyperplasia. Systematic overview]R Berges, K Höfner
Der Urologe. Ausg. A|August 17, 2014
[Certification system in urological healthcare : a professional political evaluation]R Berges, A Schroeder
Clinical Chemistry|February 1, 1993
Programming events in the regulation of cell proliferation and deathR Berges, J T Isaacs
European Urology|November 24, 1999
Management of the BPH syndrome in Germany: who is treated and how?R R Berges, L Pientka
European Urology|June 1, 2000
Effect of beta-sitosterol on transforming growth factor-beta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitroA Kassen, R Berges, T Senge
Pageof 4